Lipidoses - 55 Studies Found
Completed |
: Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease :
: Drug: Cerezyme Cerezyme doses of 20-60U/kg every 2 weeks (Q2 Arm) or 40-120 U/kg every 4 weeks (Q4 Arm). |
Completed |
: A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients :
: Drug: Eliglustat tartrate Eliglustat (Genz-112638) capsule as single 50 mg dose on Day 1 then eliglustat |
Completed |
: Evaluation of Antioxidant Activity of Oral Lutein in Preterm and Term Newborn :
: 2014-02-17 :
|
Recruiting |
: Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy :
|
Withdrawn |
: Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction : Mixed Hyperlipoproteinemia : 2014-02-20 :
|
Withdrawn |
: Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid : Mixed Hyperlipidemia : 2013-10-25 :
|
Completed |
: Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) : Mixed Hyperlipidemia : 2006-02-07 :
|
Terminated |
: Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin. : Mixed Hyperlipidemia : 2005-08-22 :
|
Recruiting |
: Krabbe Disease Global Patient Registry : Krabbe Disease : 2016-12-06 |
Recruiting |
: LYSO-PROVE - Determine the Prognostic Value of Lyso-Gb1 for Monitoring the Progress of Gaucher Disease :
|